Search

everythinglearnresearchcommunity

for

Search:↓

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

DHT, a testosterone byproduct, causes male pattern baldness.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

HIV can cause unusual and severe skin problems that are hard to treat.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Certain drugs that block specific enzymes can help treat prostate diseases.

Ginseng, especially red ginseng, may help regrow hair and block a hair loss-related enzyme.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.